Literature DB >> 17185063

Temporomandibular disorders and headache.

Steven B Graff-Radford1.   

Abstract

Headache is a common symptom, but when severe, it may be extremely disabling. It is assumed that patients who present to dentists with headache often are diagnosed with a temporomandibular disorder (TMD), although many may have migraine. TMD as a collective term may include several clinical entities, including myogenous and arthrogenous components. Because headache and TMD are so common they may be integrated or separate entities. Nevertheless, the temporomandibular joint (TMJ) and associated orofacial structures should be considered as triggering or perpetuating factors for migraine. This article discusses the relationship between the TMJ, muscles, or other orofacial structures and headache.

Entities:  

Mesh:

Year:  2007        PMID: 17185063     DOI: 10.1016/j.cden.2006.09.005

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  14 in total

Review 1.  Orofacial pain and headache: a review and look at the commonalities.

Authors:  Steven D Bender
Journal:  Curr Pain Headache Rep       Date:  2014-03

2.  Effect of catechol-O-methyltransferase polymorphism on response to propranolol therapy in chronic musculoskeletal pain: a randomized, double-blind, placebo-controlled, crossover pilot study.

Authors:  Inna E Tchivileva; Pei Feng Lim; Shad B Smith; Gary D Slade; Luda Diatchenko; Samuel A McLean; William Maixner
Journal:  Pharmacogenet Genomics       Date:  2010-04       Impact factor: 2.089

3.  ID migraine questionnaire in temporomandibular disorders with craniofacial pain: a study by using a multidisciplinary approach.

Authors:  Carlo Di Paolo; Anna Di Nunno; Nicola Vanacore; Gianluca Bruti
Journal:  Neurol Sci       Date:  2009-06-03       Impact factor: 3.307

4.  Nitric oxide-proton stimulation of trigeminal ganglion neurons increases mitogen-activated protein kinase and phosphatase expression in neurons and satellite glial cells.

Authors:  S E Freeman; V V Patil; P L Durham
Journal:  Neuroscience       Date:  2008-10-01       Impact factor: 3.590

Review 5.  Diverse Physiological Roles of Calcitonin Gene-Related Peptide in Migraine Pathology: Modulation of Neuronal-Glial-Immune Cells to Promote Peripheral and Central Sensitization.

Authors:  Paul L Durham
Journal:  Curr Pain Headache Rep       Date:  2016-08

6.  Temporal change in headache and its contribution to the risk of developing first-onset temporomandibular disorder in the Orofacial Pain: Prospective Evaluation and Risk Assessment (OPPERA) study.

Authors:  Inna E Tchivileva; Richard Ohrbach; Roger B Fillingim; Joel D Greenspan; William Maixner; Gary D Slade
Journal:  Pain       Date:  2017-01       Impact factor: 7.926

7.  Spinal trigeminal neurons demonstrate an increase in responses to dural electrical stimulation in the orofacial formalin test.

Authors:  Alexey Y Sokolov; Olga A Lyubashina; Sergey S Panteleev
Journal:  J Headache Pain       Date:  2011-11-25       Impact factor: 7.277

8.  Chronic Temporomandibular Disorders: disability, pain intensity and fear of movement.

Authors:  Alfonso Gil-Martínez; Mónica Grande-Alonso; Ibai López-de-Uralde-Villanueva; Almudena López-López; Josué Fernández-Carnero; Roy La Touche
Journal:  J Headache Pain       Date:  2016-11-03       Impact factor: 7.277

9.  Temporomandibular disorders dysfunction in headache patients.

Authors:  Christiane-Espinola-Bandeira Melo; José-Luiz-Góes Oliveira; Alan-Chester-Feitosa Jesus; Mila-Leite-de Moraes Maia; Jonielly-Costa-Vasconcelos de Santana; Loren-Suyane-Oliveira Andrade; Jullyana-de Souza Siqueira Quintans; Lucindo-José Quintans-Junior; Paulo-César-Rodrigues Conti; Leonardo-Rigoldi Bonjardim
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-11-01

10.  The NTI-tss device for the therapy of bruxism, temporomandibular disorders, and headache - where do we stand? A qualitative systematic review of the literature.

Authors:  Henrike Stapelmann; Jens C Türp
Journal:  BMC Oral Health       Date:  2008-07-29       Impact factor: 2.757

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.